Introduction It is unknown if seasonal variation in daylight affects sleep in patients with alpha-
synucleinopathies. Our objectives were to assess month of the year related changes in …

Background Neurodegenerative diseases often alter sleep architecture, complicating the
application of the standard sleep scoring rules. There are no recommendations to overcome …

Objective Obstructive sleep apnea syndrome (OSAS) is characterized by nocturnal
intermittent hypoxemia and can increase the risk of Parkinson's disease. This study aimed to …

Background Non‐REM sleep symptoms remain poorly understood in alpha‐
synucleinopathies. Aims The aims of the study were to compare sleep stability and …

Introduction The reverse dipping blood pressure (BP) pattern is very common in α-
synucleinopathies. We aimed to explore the associations of sleep-related variables with …

Objective Sleep disorders as a preclinical symptom of synucleinopathies become more
prevalent in older adults. Synucleinopathies might be caused by the abnormal aggregation …

Study Objectives: Sleep disorders, daytime sleepiness, and autonomic dysfunction are
commonly reported among patients with multiple system atrophy and Parkinson disease …

Background: Isolated REM sleep behavior disorder (IRBD), a parasomnia characterized by
nightmares and vigorous behaviors during REM sleep, is an early manifestation of …

The global north is facing an unprecedented rise in the prevalence of neurodegenerative
diseases. The increasing incidence of Parkinson's disease is being referred to as a …

Objective The purpose of this study was to investigate the differences in actigraphy‐
measured rest‐activity patterns (eg, sleep–wake cycle, circadian rest‐activity rhythm, and …